Literature DB >> 26086239

Disparities in Lung Cancer Care and Outcomes among Elderly in a Medically Underserved State Population-A Cancer Registry-Linked Database Study.

Pramit A Nadpara1, S Suresh Madhavan2, Cindy Tworek2.   

Abstract

Despite availability of guidelines for lung cancer care, variations in lung cancer care among the elderly exist across the nation and are a cause for concern in rural and medically underserved areas. Therefore, the purpose of this study was to evaluate the patterns of lung cancer care and associated health outcomes among elderly residing in a rural and medically underserved area. The authors identified 1924 elderly lung cancer patients from the West Virginia Cancer Registry-Medicare linked database (2002-2007) and categorized them by receipt of guideline-concordant (appropriate and timely) care using guidelines from the American College of Chest Physicians, British Thoracic Society, and the RAND Corporation. Hierarchical generalized logistic models were constructed to identify variables associated with receipt of guideline-concordant care. Kaplan-Meier analysis and log-rank test were used to compare 3-year survival outcomes. Multivariate Cox proportional hazards models were constructed to estimate lung cancer mortality risk associated with nonreceipt of guideline-concordant care. Although guideline-concordant appropriate care was received by fewer than half of all patients (46.5%), of those receiving care, 78.7% received it in a timely manner. Delays in diagnosis and treatment varied significantly. Survival outcomes significantly improved with appropriate care (799 vs. 366 days; P≤0.05), but did not improve with timely care. This study highlights the critical need to address disparities in receipt of guideline-concordant lung cancer care among the elderly residing in rural and medically underserved areas. Although lung cancer diagnostic and management services are covered under the Medicare program, underutilization of these services is a concern. (Population Health Management 2016;19:109-119).

Entities:  

Mesh:

Year:  2015        PMID: 26086239      PMCID: PMC4939453          DOI: 10.1089/pop.2015.0027

Source DB:  PubMed          Journal:  Popul Health Manag        ISSN: 1942-7891            Impact factor:   2.459


  31 in total

1.  Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration.

Authors:  Mary Beth Landrum; Nancy L Keating; Elizabeth B Lamont; Samuel R Bozeman; Barbara J McNeil
Journal:  Cancer       Date:  2011-11-09       Impact factor: 6.860

Review 2.  American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

Authors:  David G Pfister; David H Johnson; Christopher G Azzoli; William Sause; Thomas J Smith; Sherman Baker; Jemi Olak; Diane Stover; John R Strawn; Andrew T Turrisi; Mark R Somerfield
Journal:  J Clin Oncol       Date:  2003-12-22       Impact factor: 44.544

3.  State-specific prevalence and trends in adult cigarette smoking--United States, 1998-2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-03-13       Impact factor: 17.586

4.  Breast and cervical cancer screening among Appalachian women.

Authors:  H Irene Hall; Robert J Uhler; Steven S Coughlin; Daniel S Miller
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-01       Impact factor: 4.254

Review 5.  Timeliness of care in patients with lung cancer: a systematic review.

Authors:  J K Olsson; E M Schultz; M K Gould
Journal:  Thorax       Date:  2009-09       Impact factor: 9.139

6.  Who gets chemotherapy for metastatic lung cancer?

Authors:  C C Earle; L N Venditti; P J Neumann; R D Gelber; M C Weinstein; A L Potosky; J C Weeks
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

7.  Lung cancer diagnostic and treatment intervals in the United States: a health care disparity?

Authors:  Jeffrey T Yorio; Yang Xie; Jingsheng Yan; David E Gerber
Journal:  J Thorac Oncol       Date:  2009-11       Impact factor: 15.609

8.  Cancer death rates--Appalachia, 1994-1998.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-06-21       Impact factor: 17.586

9.  Lung cancer. Practice organization.

Authors:  W Michael Alberts; Gerold Bepler; Todd Hazelton; John C Ruckdeschel; James H Williams
Journal:  Chest       Date:  2003-01       Impact factor: 9.410

10.  Effect of delays on prognosis in patients with non-small cell lung cancer.

Authors:  G Myrdal; M Lambe; G Hillerdal; K Lamberg; Th Agustsson; E Ståhle
Journal:  Thorax       Date:  2004-01       Impact factor: 9.139

View more
  12 in total

1.  Lung cancer care trajectory at a Canadian centre: an evaluation of how wait times affect clinical outcomes.

Authors:  G Kasymjanova; D Small; V Cohen; R T Jagoe; G Batist; W Sateren; P Ernst; C Pepe; L Sakr; J Agulnik
Journal:  Curr Oncol       Date:  2017-10-25       Impact factor: 3.677

2.  Association Between Granulocyte Colony-Stimulating Factor (G-CSF) Use and Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Among Elderly Patients with Breast, Lung, or Prostate Cancer.

Authors:  Mark D Danese; Jennifer Schenfeld; Jaime Shaw; Prasad Gawade; Akhila Balasubramanian; Michael Kelsh; Rohini K Hernandez; Gary Lyman
Journal:  Adv Ther       Date:  2022-04-16       Impact factor: 4.070

3.  Cost and Utilization of Lung Cancer End-of-Life Care Among Racial-Ethnic Minority Groups in the United States.

Authors:  Yufan Chen; Steven D Criss; Tina R Watson; Andrew Eckel; Lauren Palazzo; Angela C Tramontano; Ying Wang; Nathaniel D Mercaldo; Chung Yin Kong
Journal:  Oncologist       Date:  2019-09-09

4.  A retrospective analysis of delays in the diagnosis of lung cancer and associated costs.

Authors:  Thomas R Gildea; Stacey DaCosta Byfield; D Kyle Hogarth; David S Wilson; Curtis C Quinn
Journal:  Clinicoecon Outcomes Res       Date:  2017-05-12

5.  Accessibility of Prenatal Care Can Affect Inequitable Health Outcomes of Pregnant Women Living in Obstetric Care Underserved Areas: a Nationwide Population-Based Study.

Authors:  Mi Young Kwak; Seung Mi Lee; Tae Ho Lee; Sang Jun Eun; Jin Yong Lee; Yoon Kim
Journal:  J Korean Med Sci       Date:  2018-12-28       Impact factor: 5.354

6.  The Use of Bronchoscopy During the Coronavirus Disease 2019 Pandemic: CHEST/AABIP Guideline and Expert Panel Report.

Authors:  Momen M Wahidi; Samira Shojaee; Carla R Lamb; David Ost; Fabien Maldonado; George Eapen; Daniel A Caroff; Michael P Stevens; Daniel R Ouellette; Craig Lilly; Donna D Gardner; Kristen Glisinski; Kelly Pennington; Raed Alalawi
Journal:  Chest       Date:  2020-05-01       Impact factor: 9.410

7.  Racial and Other Healthcare Disparities in Patients With Extensive-Stage SCLC.

Authors:  Umit Tapan; Vanessa Fiorini Furtado; Muhammad Mustafa Qureshi; Peter Everett; Kei Suzuki; Kimberley S Mak
Journal:  JTO Clin Res Rep       Date:  2020-10-20

8.  Interaction between treatment delivery delay and stage on the mortality from non-small cell lung cancer.

Authors:  Fernando Conrado Abrao; Igor Renato Louro Bruno de Abreu; Roberto Odebrecht Rocha; Felipe Dourado Munhoz; João Henrique Godoy Rodrigues; Bernardo Nogueira Batista
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

9.  Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial.

Authors:  Susan Y Wu; Ann A Lazar; Matthew A Gubens; Collin M Blakely; Alexander R Gottschalk; David M Jablons; Thierry M Jahan; Victoria E H Wang; Taylor L Dunbar; Melisa L Wong; Jason W Chan; William Guthrie; Jeff Belkora; Sue S Yom
Journal:  JAMA Netw Open       Date:  2020-09-01

10.  The pervasive crisis of diminishing radiation therapy access for vulnerable populations in the United States-Part 4: Appalachian patients.

Authors:  Shearwood McClelland; Tasneem Kaleem; Mark E Bernard; Hiba Z Ahmed; Terence T Sio; Robert C Miller
Journal:  Adv Radiat Oncol       Date:  2018-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.